Business Context and Reporting Period
Company: James Hardie Industries N.V. (JHI NV)
Filing Type: Form 20-F (Annual Report)
Reporting Period: Fiscal year ended March 31, 2004
Business Overview: JHI NV is the largest manufacturer of fiber cement building products in the United States, Australia, New Zealand, and the Philippines, and the second largest in Chile. The company manufactures products for residential and commercial construction, including siding, trim, roofing, and pipes. The company is incorporated in The Netherlands and lists its securities on the Australian Stock Exchange (ASX) and the New York Stock Exchange (NYSE).
Key Financial Metrics (Fiscal Year 2004)
| Metric | 2004 (in millions) | 2003 (in millions) |
|---|---|---|
| Net Sales | $981.9 | $783.6 |
| Operating Income | $172.2 | $128.8 |
| Income from Continuing Operations | $125.3 | $83.5 |
| Net Income | $129.6 | $170.5 |
| Adjusted EBITDA | $208.6 | $156.2 |
| Cash Flow from Operating Activities | $162.6 | $64.8 |
| Capital Expenditures | $74.1 | $90.2 |
| Long-Term Debt | $147.4 | $165.0 |
| Total Assets | $971.2 | $851.8 |
| Shareholders' Equity | $504.7 | $434.7 |
Note: Net Income for 2003 includes $87.0 million from discontinued operations (Gypsum and Building Systems sales), whereas 2004 includes only $4.3 million from discontinued operations.
Material Changes vs. Prior Period
- Revenue Growth: Total net sales increased 25% to $981.9 million, driven by a 23% increase in USA Fiber Cement sales ($738.6 million) and a 26% increase in Asia Pacific Fiber Cement sales ($219.8 million). The USA segment accounted for 75% of total sales.
- Profitability: Operating income rose 34% to $172.2 million. Income from continuing operations increased 50% to $125.3 million. The operating margin improved to 17.5% from 16.4%.
- Discontinued Operations: The company successfully divested its Gypsum business in 2002 and Building Systems business in 2003. Consequently, income from discontinued operations dropped significantly from $87.0 million in 2003 to $4.3 million in 2004.
- Interest Expense: Net interest expense decreased by $9.9 million, primarily due to the absence of a $9.9 million make-whole payment incurred in 2003 for the early retirement of debt.
- Capital Expenditures: Capital spending decreased to $74.1 million from $90.2 million, though significant projects were underway, including a new green-field plant in Reno, Nevada.
Guidance, Outlook, Risks, and Contingencies
Management Commentary and Outlook
Management expects continued strong top-line growth in North America due to favorable housing market conditions. However, the first half of fiscal 2005 saw negative impacts from higher ramp-up costs and manufacturing inefficiencies, which management expects to resolve in the second half. The company anticipates pulp prices may decrease in the third quarter of fiscal 2005. In Australia and New Zealand, the outlook is softer due to expected interest rate hikes and potential product boycotts related to the Special Commission of Inquiry (SCI).
Material Risks and Contingencies
- Special Commission of Inquiry (SCI): The NSW Government established the SCI to investigate the funding of the Medical Research and Compensation Foundation (asbestos claims). The SCI found a significant funding shortfall (estimated A$1.57 billion) and that the Foundation's assets would likely be exhausted by mid-2007. While the SCI found the corporate restructuring legally effective, the NSW Government has threatened legislation to "wind back" the restructuring if a negotiated settlement is not reached. The company is in discussions with union representatives and the government, but the outcome is highly uncertain.
- Asbestos Liability: Although the company believes it has no liability under current Australian law for the asbestos claims of former subsidiaries (Amaca, Amaba, ABN 60), the potential for legislative changes or court rulings could expose the company to significant liabilities, potentially resulting in negative shareholders' equity.
- Management Transition: The CEO (Peter Macdonald) and CFO (Peter Shafron) resigned in October 2004 following the SCI report. Interim leadership (Louis Gries as CEO, Russell Chenu as CFO) was appointed. The company notes risks associated with the transition and the distraction of management focusing on the SCI.
- Tax Treaty Changes: A new protocol to the U.S.-Netherlands tax treaty, if ratified, could increase the company's effective tax rate significantly starting in fiscal 2006 unless the company reorganizes its structure.
- ASIC Investigation: The Australian Securities and Investments Commission is investigating potential contraventions of Australian laws arising from transactions considered by the SCI.
Key Facts for Investor Verification
- Asbestos Resolution Status: Verify the current status of negotiations between James Hardie, the Australian Council of Trade Unions (ACTU), and the NSW Government regarding the funding of the asbestos compensation scheme.
- Legislative Threats: Monitor for any draft legislation from the NSW or Australian Federal Government intended to reverse the corporate restructuring or enforce liability on the Dutch parent company.
- Management Stability: Confirm the appointment of permanent CEO and CFO successors to replace the interim leadership appointed in October 2004.
- Tax Structure: Assess the company's progress in restructuring its operations to maintain tax benefits under the amended U.S.-Netherlands tax treaty.
- Capital Expenditure Execution: Track the completion and cost overruns of the new Reno, Nevada plant and the trim line at the Peru, Illinois plant, which are critical for future capacity.